|
On 20 August 2015, 15 September 2015, 23 October 2015 and 3rd December 2015, Omega Pharma Invest NV (registered with the CSSF under the issuer number E-1058) was fined by the CSSF according to Article 25(1) of the law of 11 January 2008 on transparency requirements for issuers of securities (the “Transparency Law“).
The CSSF noticed that the issuer in question failed to act in response to orders of the CSSF and did not comply with the CSSF’s request for information, in relation to:
- the CSSF’s right to examine that periodic information referred to in the Transparency Law is drawn up in accordance with the relevant reporting framework and take appropriate measures in case of discovered infringements, as per Article 22(2)(h) of the Transparency Law;
-...
|